Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Treasury Shares: 2011-2025

Historic Treasury Shares for Madrigal Pharmaceuticals (MDGL) over the last 7 years, with Sep 2025 value amounting to $779,923.

  • Madrigal Pharmaceuticals' Treasury Shares rose 55.10% to $779,923 in Q3 2025 from the same period last year, while for Sep 2025 it was $779,923, marking a year-over-year increase of 55.10%. This contributed to the annual value of $499,559 for FY2024, which is 32.82% up from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Treasury Shares of $779,923 as of Q3 2025, which was up 2.99% from $757,263 recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Treasury Shares ranged from a high of $779,923 in Q3 2025 and a low of $199,125 during Q1 2023.
  • In the last 3 years, Madrigal Pharmaceuticals' Treasury Shares had a median value of $502,867 in 2024 and averaged $489,412.
  • Data for Madrigal Pharmaceuticals' Treasury Shares shows a peak YoY spiked of 166.50% (in 2024) over the last 5 years.
  • Over the past 3 years, Madrigal Pharmaceuticals' Treasury Shares (Quarterly) stood at $376,117 in 2023, then surged by 32.82% to $499,559 in 2024, then soared by 55.10% to $779,923 in 2025.
  • Its last three reported values are $779,923 in Q3 2025, $757,263 for Q2 2025, and $694,995 during Q1 2025.